13FPulse
TE

TEVA TEVA PHARMACEUTICAL-SP ADR

2026Q2 · CUSIP 881624209 · Sector: Healthcare & Biotech

Cooling

Net holder growth weakened from last quarter

Funds that own it
663
Institutions that reported holding it to the SEC
Net increase in holders
+13
Last quarter 650 → now 663
How unusual is that
Above average
Stronger buying than 75% of US stocks
What the filings say, in one paragraph

663 funds held TEVA at the end of 2026Q2, up 13 from the quarter before. Buying has come off its highs, but funds are not exiting. On the business itself, revenue over the last 12 months was $17.3B(YoY +4.1%), the P/E is 59.7x, return on equity is 9.1%. TEVA has had 15 buying rushes in its history, and the price moved +0.1% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=703 2013Q4: holders=723 2014Q1: holders=768 2014Q2: holders=778 2014Q3: holders=767 2014Q4: holders=819 2015Q1: holders=817 2015Q2: holders=816 2015Q3: holders=823 2015Q4: holders=875 2016Q1: holders=834 2016Q2: holders=808 2016Q3: holders=796 2016Q4: holders=738 2017Q1: holders=687 2017Q2: holders=649 2017Q3: holders=534 2017Q4: holders=509 2018Q1: holders=508 2018Q2: holders=540 2018Q3: holders=554 2018Q4: holders=549 2019Q1: holders=521 2019Q2: holders=451 2019Q3: holders=429 2019Q4: holders=439 2020Q1: holders=459 2020Q2: holders=456 2020Q3: holders=444 2020Q4: holders=453 2021Q1: holders=451 2021Q2: holders=436 2021Q3: holders=429 2021Q4: holders=447 2022Q1: holders=438 2022Q2: holders=454 2022Q3: holders=431 2022Q4: holders=421 2023Q1: holders=437 2023Q2: holders=425 2023Q3: holders=432 2023Q4: holders=446 2024Q1: holders=479 2024Q2: holders=535 2024Q3: holders=543 2024Q4: holders=586 2025Q1: holders=560 2025Q2: holders=542 2025Q3: holders=550 2025Q4: holders=631 2026Q1: holders=650 2026Q2: holders=663 -115 -57.5 +0 +57.5 +115 378649919 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 15 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 20% +1.8%
2025Q4 Top 5% -13.1% -0.0%
2024Q4 Top 20% -5.9% +4.2%
2024Q2 Top 5% -3.2% -8.3%
2024Q1 Top 10% +3.3% +12.3%
2023Q1 Top 20% -8.0% +17.0%
2022Q2 Top 10% -19.4% -8.3%
2020Q1 Top 5% -3.6% -1.5%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
262
Change in large funds
+21
Total value they hold
$24.7B
Funds buying for the first time
87
Funds that sold out entirely
74
Price change that quarter
+7.1%
Funds holding puts (bearish)
17
Funds holding calls (bullish)
21

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
59.7
EPS (TTM)
$0.61
EPS YoY
Revenue (TTM)
$17.3B
Revenue YoY
+4.1%
Net margin
4.1%
ROE
9.1%
Debt ratio
80.5%
FCF (TTM)
$1.3B
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2022-09-30: EPS 0.05 2022-12-31: EPS -1.17 2023-03-31: EPS -0.20 2023-06-30: EPS -0.78 2023-09-30: EPS 0.06 2023-12-31: EPS 0.42 2024-03-31: EPS -0.12 2024-06-30: EPS -0.75 2024-09-30: EPS -0.39 2024-12-31: EPS -0.19 2025-03-31: EPS 0.18 2025-06-30: EPS 0.24 2025-09-30: EPS 0.37 2025-12-31: EPS 0.42 2026-03-31: EPS 0.31 2026-06-30: EPS -0.49 0B 3.2B 6.5B $B -1.29 -0.41 0.46 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
23 43 63 20252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-555M389M1.3B 2017201820192020202120222023202420252026
Latest quarter $-208M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.